InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
VGX | Ann:Market Update - Conditional Sale of Shares (Price Sensitive) | 09/02/24 | 0 | 1 | |||
|
|||||||
VGX | Ann:Change in Director's Interest Notice - Eric CHUNG | 09/02/24 | 0 | 1 | |||
|
|||||||
VGX | Ann:Change in Director's Interest Notice - KONG Teck Chin | 09/02/24 | 0 | 1 | |||
|
|||||||
VGX | Ann:Change in Director's Interest Notice - YAP Poh Yee | 09/02/24 | 0 | 1 | |||
|
|||||||
VGX | Ann:Change in Substantial Shareholder -Eric CHUNG Chi Kong | 09/02/24 | 0 | 1 | |||
|
|||||||
VGX | Ann:Change in Substantial Shareholder - KONG Teck Chin | 09/02/24 | 0 | 1 | |||
|
|||||||
VGX | Ann:Cease to be a Substantial Shareholder - YAP Poh Yeel | 09/02/24 | 0 | 1 | |||
|
|||||||
VGX | Ann:Initial Substantial Holder - Stemawe Holdings Limited | 09/02/24 | 0 | 1 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |